Neoadjuvant abemaciclib for HR positive, HER negative breast cancer
Neoadjuvant abemaciclib for HR positive, HER negative breast cancer
TCHP with/out oestrogen for HR/HER positive breast cancer
Efficacy of veliparib with carboplatin and paclitaxel for BRCA1/2 mutations in metastatic breast cancer
Extended adjuvant endrocine therapy with letrozole after aromatase inhibition
Whole exome and transcriptome sequencing of resistant ER positive metastatic breast cancer
PrECOG: Added everolimus extends PFS for HR positive, HER2 negative breast cancer
Interim results from the ZUMA-1 trial of novel CAR-T cells against non-Hodgkin lymphoma
Pacritinib versus best available therapy for low platelet Myelofibrosis
ASH 2016 highlights: breaking new ground in haematology
TCA cycle inhibition by CPI-613 increases chemo sensitivity in older AML patients
Azacitidine plus nivolumab against acute myeloid leukaemia
IKZF1 mutations associated with paediatric ALL